Figure 6From: Quantifying spectral changes experienced by plasmonic nanoparticles in a cellular environment to inform biomedical nanoparticle designDistribution of spectral peak wavelengths measured from different cells of same population. Cells were exposed to (A) 12, (B) 24, (C) 48, and (D) 96 μg/mL of AuNPs for 2, 5, 10, or 24 h. Cell ROI spectral peak wavelengths among different cells increase in diversity with time. To note, at 2 h, only cells exposed to the 96 μg/mL dose of AuNPs (D) exhibited optical spectra for which a peak wavelength could be determined. At all lower exposure doses (A, B, C) at 2 h, the measured spectra was dominated by cell scattering.Back to article page